MondegarAI
FINDELL CAPITAL MANAGEMENT LLC

Q4 2025 · 13F-HR

FINDELL CAPITAL MANAGEMENT LLCholdings as filed

Filed 2026-02-17 · accession 0000921895-26-000470

$347.8M
Reported value
17
Positions
2025-12-31
Period end
View analyzed profile →PRO

The Brief · FINDELL CAPITAL MANAGEMENT LLC · Q4 2025

AI · grounded in 13F

FINDELL CAPITAL MANAGEMENT LLC closed its position in THE ODP CORP ODP1, reducing exposure by $14.87M. The fund established new positions in CELSIUS HLDGS INC CELH for $9.61M and STRIDE INC LRN for $5.84M. Additionally, the manager exited positions in PEABODY ENERGY CORP BTU and SEZZLE INC SEZL.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
53635D202LQDALIQUIDIA CORPORATION$98.3M28.3%2,851,449CommonSOLE
G31249108ESTAESTABLISHMENT LABS HLDGS INC$82.4M23.7%1,130,460CommonSOLE
53635D202LQDALIQUIDIA CORPORATION$41.4M11.9%1,200,000PUTSOLE
77664L207ROOTROOT INC$17.0M4.88%235,000CommonSOLE
23834J201DAVEDAVE INC$15.5M4.46%70,000CommonSOLE
90041L105TPBTURNING PT BRANDS INC$13.8M3.96%127,000CommonSOLE
68376D104OPRTOPORTUN FINL CORP$13.6M3.91%2,568,300CommonSOLE
G8588X103SGHCSUPER GROUP SGHC LIMITED$11.2M3.23%940,000CommonSOLE
36162J106GEOGEO GROUP INC NEW$10.5M3.01%650,000CommonSOLE
15118V207CELHCELSIUS HLDGS INC$9.6M2.76%210,000CommonSOLE
28238P109EHTHEHEALTH INC$6.5M1.86%1,408,975CommonSOLE
00370M103ABVXABIVAX SA$6.5M1.86%48,000CommonSOLE
86333M108LRNSTRIDE INC$5.8M1.68%90,000CommonSOLE
000899104ADMAADMA BIOLOGICS INC$5.5M1.57%300,000CommonSOLE
53635D202LQDALIQUIDIA CORPORATION$5.4M1.55%156,000CALLSOLE
929033207VORVOR BIOPHARMA INC$3.0M0.87%231,000CommonSOLE
603170101MLYSMINERALYS THERAPEUTICS INC$1.8M0.52%50,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.